학술논문

LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
Document Type
Article
Source
Arteriosclerosis, Thrombosis & Vascular Biology; Dec2021, Vol. 41 Issue 12, p3005-3014, 10p
Subject
Language
ISSN
10795642